应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TVGN Tevogen Bio Holdings
已收盘 07-30 16:00:00 EDT
1.02
-0.02
-1.92%
盘后
1.02
+0.00
0.00%
19:40 EDT
最高
1.08
最低
1.00
成交量
89.63万
今开
1.04
昨收
1.04
日振幅
7.63%
总市值
1.98亿
流通市值
1,993万
总股本
1.94亿
成交额
92.08万
换手率
4.59%
流通股本
1,954万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Tevogen Bio Holdings Inc.盘中异动 快速拉升5.04%报1.25美元
市场透视 · 07-14
Tevogen Bio Holdings Inc.盘中异动 快速拉升5.04%报1.25美元
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.08%报1.24美元
市场透视 · 06-27
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.08%报1.24美元
Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.00%
市场透视 · 06-23
Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.00%
Tevogen Bio Holdings Inc.盘中异动 临近收盘股价大跌5.22%报1.27美元
市场透视 · 06-12
Tevogen Bio Holdings Inc.盘中异动 临近收盘股价大跌5.22%报1.27美元
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.65%报1.31美元
市场透视 · 06-11
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.65%报1.31美元
Tevogen Bio Holdings Inc.盘中异动 早盘快速下挫5.59%
市场透视 · 06-09
Tevogen Bio Holdings Inc.盘中异动 早盘快速下挫5.59%
Tevogen Bio Holdings Inc.盘中异动 股价大跌5.22%
市场透视 · 05-30
Tevogen Bio Holdings Inc.盘中异动 股价大跌5.22%
Tevogen Bio Holdings Inc.盘中异动 快速上涨6.36%报1.26美元
市场透视 · 05-22
Tevogen Bio Holdings Inc.盘中异动 快速上涨6.36%报1.26美元
Tevogen Bio Holdings Inc.盘中异动 早盘急速下挫5.17%报1.10美元
市场透视 · 05-14
Tevogen Bio Holdings Inc.盘中异动 早盘急速下挫5.17%报1.10美元
Tevogen Bio Holdings Inc.盘中异动 快速上涨5.29%
市场透视 · 05-08
Tevogen Bio Holdings Inc.盘中异动 快速上涨5.29%
Tevogen Bio Holdings Inc.盘中异动 下午盘急速上涨5.94%报1.070美元
市场透视 · 05-05
Tevogen Bio Holdings Inc.盘中异动 下午盘急速上涨5.94%报1.070美元
Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.27%
市场透视 · 05-02
Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.27%
Tevogen Bio Holdings Inc.盘中异动 早盘急速跳水5.27%
市场透视 · 05-01
Tevogen Bio Holdings Inc.盘中异动 早盘急速跳水5.27%
Tevogen Bio Holdings Inc.盘中异动 早盘大幅跳水5.03%
市场透视 · 04-30
Tevogen Bio Holdings Inc.盘中异动 早盘大幅跳水5.03%
Tevogen Bio Holdings Inc.盘中异动 早盘大幅上涨15.21%报1.080美元
市场透视 · 04-29
Tevogen Bio Holdings Inc.盘中异动 早盘大幅上涨15.21%报1.080美元
Tevogen Bio Holdings Inc.盘中异动 快速拉升5.11%报0.980美元
市场透视 · 04-22
Tevogen Bio Holdings Inc.盘中异动 快速拉升5.11%报0.980美元
Tevogen Bio Holdings Inc.盘中异动 快速下跌5.06%报0.930美元
市场透视 · 04-21
Tevogen Bio Holdings Inc.盘中异动 快速下跌5.06%报0.930美元
Tevogen Bio Holdings Inc.盘中异动 急速下挫5.87%
市场透视 · 04-17
Tevogen Bio Holdings Inc.盘中异动 急速下挫5.87%
Tevogen Bio Holdings Inc.盘中异动 急速拉升5.62%报1.11美元
市场透视 · 04-15
Tevogen Bio Holdings Inc.盘中异动 急速拉升5.62%报1.11美元
Tevogen Bio Holdings Inc.盘中异动 早盘快速跳水5.56%
市场透视 · 04-14
Tevogen Bio Holdings Inc.盘中异动 早盘快速跳水5.56%
加载更多
公司概况
公司名称:
Tevogen Bio Holdings
所属市场:
NASDAQ
上市日期:
--
主营业务:
Tevogen Bio Holdings Inc.于2021年4月21日在开曼群岛注册成立,后合并重组为特拉华州公司。Tevogen Bio是一家临床阶段的专业免疫疗法公司,利用自然界最强大的免疫武器之一—CD8 +细胞毒性T淋巴细胞,开发现成的、未经基因改造的精准T细胞疗法,用于治疗传染病、癌症和神经系统疾病,旨在解决大量患者群体的重大未满足需求。
发行价格:
--
{"stockData":{"symbol":"TVGN","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings","latestPrice":1.02,"timestamp":1753905600000,"preClose":1.04,"halted":0,"volume":896338,"hourTrading":{"tag":"盘后","latestPrice":1.02,"preClose":1.02,"latestTime":"19:40 EDT","volume":14192,"amount":14544.7589,"timestamp":1753918821985},"delay":0,"floatShares":19535200,"shares":194000000,"eps":-0.204889,"marketStatus":"已收盘","change":-0.02,"latestTime":"07-30 16:00:00 EDT","open":1.04,"high":1.0794,"low":1,"amount":920774.3250912,"amplitude":0.076346,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.204889,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753948800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":1.04,"preHourTrading":{"tag":"盘前","latestPrice":1.04,"preClose":1.04,"latestTime":"09:29 EDT","volume":11699,"amount":12169.1114461,"timestamp":1753882199906},"postHourTrading":{"tag":"盘后","latestPrice":1.02,"preClose":1.02,"latestTime":"19:40 EDT","volume":14192,"amount":14544.7589,"timestamp":1753918821985},"volumeRatio":2.009368},"requestUrl":"/m/hq/s/TVGN","defaultTab":"news","newsList":[{"id":"2551872081","title":"Tevogen Bio Holdings Inc.盘中异动 快速拉升5.04%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551872081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551872081?lang=zh_cn&edition=full","pubTime":"2025-07-14 22:09","pubTimestamp":1752502167,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日22时09分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅上涨5.04%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.95%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714220927a6a9013d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714220927a6a9013d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2546729166","title":"Tevogen Bio Holdings Inc.盘中异动 股价大涨5.08%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546729166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546729166?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:55","pubTimestamp":1751054113,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时55分,Tevogen Bio Holdings Inc.股票出现异动,股价快速上涨5.08%。截至发稿,该股报1.24美元/股,成交量54.4329万股,换手率0.30%,振幅8.05%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.84%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035513a4c1cba0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035513a4c1cba0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2545417378","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545417378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545417378?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:31","pubTimestamp":1750685499,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时31分,Tevogen Bio Holdings Inc.股票出现异动,股价快速下挫5.00%。截至发稿,该股报1.14美元/股,成交量9.8243万股,换手率0.05%,振幅0.00%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.30%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213139a718f0c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213139a718f0c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2543254405","title":"Tevogen Bio Holdings Inc.盘中异动 临近收盘股价大跌5.22%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543254405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543254405?lang=zh_cn&edition=full","pubTime":"2025-06-13 03:37","pubTimestamp":1749757031,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日03时37分,Tevogen Bio Holdings Inc.股票出现波动,股价急速跳水5.22%。截至发稿,该股报1.27美元/股,成交量48.2294万股,换手率0.26%,振幅5.97%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.73%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613033711a705e614&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613033711a705e614&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2542953972","title":"Tevogen Bio Holdings Inc.盘中异动 股价大涨5.65%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542953972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542953972?lang=zh_cn&edition=full","pubTime":"2025-06-12 01:03","pubTimestamp":1749661425,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日01时03分,Tevogen Bio Holdings Inc.股票出现异动,股价快速上涨5.65%。截至发稿,该股报1.31美元/股,成交量32.4082万股,换手率0.18%,振幅5.65%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.62%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612010345a4a3c9ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612010345a4a3c9ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2542771380","title":"Tevogen Bio Holdings Inc.盘中异动 早盘快速下挫5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542771380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542771380?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:39","pubTimestamp":1749476364,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时39分,Tevogen Bio Holdings Inc.股票出现波动,股价快速下跌5.59%。截至发稿,该股报1.35美元/股,成交量10.0639万股,换手率0.05%,振幅4.90%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092139259514d65c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092139259514d65c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2539427100","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539427100","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539427100?lang=zh_cn&edition=full","pubTime":"2025-05-31 00:58","pubTimestamp":1748624284,"startTime":"0","endTime":"0","summary":"北京时间2025年05月31日00时58分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅下跌5.22%。截至发稿,该股报1.27美元/股,成交量139.662万股,换手率0.76%,振幅8.96%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为4.44%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531005804a6f39ceb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531005804a6f39ceb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2537247559","title":"Tevogen Bio Holdings Inc.盘中异动 快速上涨6.36%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537247559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537247559?lang=zh_cn&edition=full","pubTime":"2025-05-23 04:01","pubTimestamp":1747944062,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日04时01分,Tevogen Bio Holdings Inc.股票出现波动,股价快速上涨6.36%。截至发稿,该股报1.26美元/股,成交量47.9705万股,换手率0.26%,振幅6.78%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.46%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052304010394ff7e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052304010394ff7e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2535071719","title":"Tevogen Bio Holdings Inc.盘中异动 早盘急速下挫5.17%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535071719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535071719?lang=zh_cn&edition=full","pubTime":"2025-05-14 23:24","pubTimestamp":1747236240,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日23时24分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅下挫5.17%。截至发稿,该股报1.10美元/股,成交量17.8042万股,换手率0.10%,振幅4.76%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.95%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051423240097599b53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051423240097599b53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2533539071","title":"Tevogen Bio Holdings Inc.盘中异动 快速上涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533539071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533539071?lang=zh_cn&edition=full","pubTime":"2025-05-08 23:43","pubTimestamp":1746718986,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日23时43分,Tevogen Bio Holdings Inc.股票出现波动,股价急速上涨5.29%。截至发稿,该股报1.10美元/股,成交量18.8065万股,换手率0.10%,振幅5.29%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为2.55%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505082343079753646e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505082343079753646e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2533552365","title":"Tevogen Bio Holdings Inc.盘中异动 下午盘急速上涨5.94%报1.070美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533552365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533552365?lang=zh_cn&edition=full","pubTime":"2025-05-06 01:10","pubTimestamp":1746465029,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日01时10分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅上涨5.94%。截至发稿,该股报1.070美元/股,成交量28.6442万股,换手率0.16%,振幅7.62%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.35%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506011029aa2c8357&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506011029aa2c8357&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2532352825","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532352825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532352825?lang=zh_cn&edition=full","pubTime":"2025-05-02 23:08","pubTimestamp":1746198539,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日23时08分,Tevogen Bio Holdings Inc.股票出现异动,股价急速上涨5.27%。截至发稿,该股报1.030美元/股,成交量30.2157万股,换手率0.16%,振幅5.25%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为1.16%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502230859974d7285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502230859974d7285&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2532600591","title":"Tevogen Bio Holdings Inc.盘中异动 早盘急速跳水5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532600591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532600591?lang=zh_cn&edition=full","pubTime":"2025-05-01 22:05","pubTimestamp":1746108351,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日22时05分,Tevogen Bio Holdings Inc.股票出现波动,股价快速下跌5.27%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.77%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050122055194e9fb25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050122055194e9fb25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2531005866","title":"Tevogen Bio Holdings Inc.盘中异动 早盘大幅跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531005866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531005866?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:33","pubTimestamp":1746019991,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时33分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅跳水5.03%。截至发稿,该股报0.959美元/股,成交量35.6348万股,换手率0.19%,振幅3.24%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.30%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213311974ba08c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213311974ba08c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2531737522","title":"Tevogen Bio Holdings Inc.盘中异动 早盘大幅上涨15.21%报1.080美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531737522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531737522?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:31","pubTimestamp":1745933514,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时31分,Tevogen Bio Holdings Inc.股票出现异动,股价急速上涨15.21%。截至发稿,该股报1.080美元/股,成交量658.922万股,换手率3.58%,振幅4.29%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为1.78%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213154a6cd6993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213154a6cd6993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2529553473","title":"Tevogen Bio Holdings Inc.盘中异动 快速拉升5.11%报0.980美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529553473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529553473?lang=zh_cn&edition=full","pubTime":"2025-04-23 00:37","pubTimestamp":1745339873,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日00时37分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅上涨5.11%。截至发稿,该股报0.980美元/股,成交量14.3263万股,换手率0.08%,振幅3.51%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为2.05%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042300375394de5f3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042300375394de5f3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2529365553","title":"Tevogen Bio Holdings Inc.盘中异动 快速下跌5.06%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529365553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529365553?lang=zh_cn&edition=full","pubTime":"2025-04-22 01:17","pubTimestamp":1745255825,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日01时17分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅下跌5.06%。截至发稿,该股报0.930美元/股,成交量13.6958万股,换手率0.07%,振幅3.81%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.49%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422011705a4615957&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422011705a4615957&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2528741021","title":"Tevogen Bio Holdings Inc.盘中异动 急速下挫5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528741021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528741021?lang=zh_cn&edition=full","pubTime":"2025-04-17 22:20","pubTimestamp":1744899645,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日22时20分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅跳水5.87%。截至发稿,该股报0.960美元/股,成交量5.744万股,换手率0.03%,振幅4.55%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041722204594d8de62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041722204594d8de62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2527429586","title":"Tevogen Bio Holdings Inc.盘中异动 急速拉升5.62%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527429586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527429586?lang=zh_cn&edition=full","pubTime":"2025-04-16 02:21","pubTimestamp":1744741260,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日02时21分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅上涨5.62%。截至发稿,该股报1.11美元/股,成交量29.3171万股,换手率0.16%,振幅7.62%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.74%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416022101a45a0a01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416022101a45a0a01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2527191272","title":"Tevogen Bio Holdings Inc.盘中异动 早盘快速跳水5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527191272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527191272?lang=zh_cn&edition=full","pubTime":"2025-04-14 23:20","pubTimestamp":1744644034,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日23时20分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅下跌5.56%。截至发稿,该股报1.02美元/股,成交量23.9569万股,换手率0.13%,振幅4.63%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为2.33%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414232034a458a260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414232034a458a260&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://semperparatusspac.com","stockEarnings":[{"period":"1week","weight":-0.0631},{"period":"1month","weight":-0.1613},{"period":"3month","weight":0.0097},{"period":"6month","weight":-0.2239},{"period":"1year","weight":0.5522},{"period":"ytd","weight":0.0097}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0331},{"period":"3month","weight":0.1456},{"period":"6month","weight":0.0499},{"period":"1year","weight":0.1661},{"period":"ytd","weight":0.0839}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tevogen Bio Holdings Inc.于2021年4月21日在开曼群岛注册成立,后合并重组为特拉华州公司。Tevogen Bio是一家临床阶段的专业免疫疗法公司,利用自然界最强大的免疫武器之一—CD8 +细胞毒性T淋巴细胞,开发现成的、未经基因改造的精准T细胞疗法,用于治疗传染病、癌症和神经系统疾病,旨在解决大量患者群体的重大未满足需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.026634},{"month":2,"riseRate":0.75,"avgChangeRate":0.093777},{"month":3,"riseRate":0.5,"avgChangeRate":-0.166085},{"month":4,"riseRate":0.5,"avgChangeRate":-0.189171},{"month":5,"riseRate":0.25,"avgChangeRate":0.008552},{"month":6,"riseRate":0.25,"avgChangeRate":-0.034979},{"month":7,"riseRate":0.5,"avgChangeRate":-0.068435},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.058816},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.094697},{"month":10,"riseRate":1,"avgChangeRate":1.958555},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.153562},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.065928}],"exchange":"NASDAQ","name":"Tevogen Bio Holdings","nameEN":"Tevogen Bio Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tevogen Bio Holdings(TVGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings(TVGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tevogen Bio Holdings,TVGN,Tevogen Bio Holdings股票,Tevogen Bio Holdings股票老虎,Tevogen Bio Holdings股票老虎国际,Tevogen Bio Holdings行情,Tevogen Bio Holdings股票行情,Tevogen Bio Holdings股价,Tevogen Bio Holdings股市,Tevogen Bio Holdings股票价格,Tevogen Bio Holdings股票交易,Tevogen Bio Holdings股票购买,Tevogen Bio Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tevogen Bio Holdings(TVGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings(TVGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}